theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Pulmonology

NCI-CCC Thoracic Tumor Board Question   

Questions discussed in this category


What is the role for "liquid biopsy" for patients with newly diagnosed metastatic NSCLC?
5 Answers available

What is your preferred management for diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)?
Does your management change if symptomatic or asymptomatic?
1 Answer available

How has COVID-19 altered your recommendations for invasive mediastinal staging for NSCLC?
Should staging and treatment decisions be made based on imaging alone?
2 Answers available
5028149116816


Papers discussed in this category


Chest, 2020 Aug 14
Clinical Characteristics of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Retrospective Analysis.

Chest, 2020 Jul
Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell Hyperplasia.

ERJ Open Res, 2020 Oct
Constrictive bronchiolitis in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

Related Topics in Pulmonology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Melanoma/Skin Cancer

Copyright © 2025 theMednet
All Rights Reserved.